Myasthenia gravis (MG) is a type of muscle paralysis created by immune responses against
acetylcholine receptor proteins in neuromuscular synapses. This disease is characterized by …

Myasthenia gravis (MG) is a rare acquired autoimmune neuromuscular disease.
Autoantibodies, cellular immunity, complement, and cytokines are involved in the …

Myasthenia gravis (MG) is an autoimmune condition related to autoantibodies against
certain proteins in the postsynaptic membranes in the neuromuscular junction. This disorder …

Background Studies have described the role of microRNAs (miRNAs) in thymic function,
along with directly observing the altered expression of miRNAs in thymuses of myasthenia …

Myasthenia gravis (MG) is a classic autoimmune neuromuscular disease with strong clinical
heterogeneity. The concept of subgroup classification was proposed to guide the precise …

Myasthenia gravis (MG) is an autoimmune neuromuscular disease characterized by
fatigable skeletal muscle weakness with a fluctuating unpredictable course. One main …

Myasthenia gravis (MG) is a neuromuscular autoimmune disorder resulting from
autoantibodies attacking components of the neuromuscular junction. Recent studies have …

Myasthenia gravis (MG) is an autoimmune disease caused by antibodies which attack
receptors at the neuromuscular junction. One of the main difficulties in predicting the clinical …

Myasthenia gravis (MG) is an autoimmune disease characterized by the presence of
autoantibodies, mainly against the acetylcholine receptor (AChR). The mechanisms …

Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission
currently treated with chronic immunosuppression. Inter-subject variation in treatment …